The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: -0.25 (-3.28%)
Spread: 0.25 (3.448%)
Open: 7.625
High: 7.625
Low: 7.375
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Andrada raises GBP7.7 million; Ixico signs contract

Tue, 18th Jul 2023 16:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Ixico PLC - London-based precision analytics company delivering insights in neuroscience - Signs a contract with a new, unnamed client. Under the agreement, Ixico will provide its imaging services in a clinical trial of a novel therapeutic to treat progressive supranuclear palsy, a rare neurodegenerative disease. Says the contract value is about USD1.7 million, over a four-year term. Chief Executive Giulio Cerroni says: "Rare diseases are a global health priority with about 95% of all rare diseases not yet having treatments. This new contract exemplifies the traction we are building beyond our strong market position in HD into other rare neuro disorders to expand our market opportunities and acquire new clients in the dynamic field of rare neurological diseases."

----------

DX Group PLC - Slough, England-based provider of delivery solutions, including parcel freight, secure courier and logistics services - Says that it has traded in line with management's expectations during the second half of the company's financial year ended July 1. Revenue for the financial year is expected to be 10% ahead of the prior year at GBP470 million, up from GBP428 million. Says net cash at July 1 was up by 39% to GBP37.6 million from GBP27.0 million, which it says is slightly ahead of management's target. Both DX Freight and DX Express contributed increased revenue and achieved margin gains, it adds. Looking ahead, DX says it remains "encouraged about growth prospects", despite the current economic headwinds. Plans to publish its full-year results in early October.

----------

Judges Scientific PLC - London-based acquirer of scientific-instrument companies - Says that organic order intake in the first half of 2023 was up 14% year-on-year. Adds that it was up in all major regions, signalling improving prospects across markets, with the most notable being China/Hong Kong. North America was up 6.6%, the UK up 9.0%, the rest of Europe up 7.5% and the rest of the world up 3.5%. Says organic revenue in the first half was up 17% compared with the first half of 2022, illustrating some progress with supply chain issues. Noted that two "small acquisitions" were completed during the first half, Henniker Scientific Ltd and Bossa Nova Vision LLC. "The strong order book, and the general resilience of Judges' business give the board confidence that the current market expectations for the full year will be met," Judges says, looking ahead. Plans on announcing its interim results on September 20.

----------

Gulf Marine Services PLC - United Arab Emirates-based lift boat company - Says that financing charges will decline as paid in kind interest stops accruing as of the second quarter, as a result of net leverage dropping below 4:1. This means that moving forward, the cost of funds will decrease by 340 basis points. Executive Chair Mansour Al Alami says: "We are delighted to make this announcement that confirms that our continuous commitment to deleverage is successful in moving value from lenders to shareholders. Reaching this milestone will enable us to better face all other challenges while continuing our deleveraging journey."

----------

Bloomsbury Publishing PLC - London-based publisher - Says trading has been in line with expectations following a good performance in the first four months of its financial year. Says it has maintained year-on-year sales growth of 9% in the four months ended June 30. "The board remains confident in Bloomsbury's ability to continue to deliver long-term success, with significant financial resources available to invest in organic growth and further company acquisitions. Global diversification across channels and markets continues to serve us well and further underpins our positive outlook," it adds. The results for the six months ending August 31 will be announced on October 26.

----------

Marlowe PLC - London-based software & service provider for safety and regulatory compliance - Says a resolution was passed by shareholders to cancel the balance standing to the credit of the company's share premium account. In doing so, the company will increase its distributable reserves by GBP384.9 million. Says it remains focussed on the continued execution of its growth strategy, and the capital reduction now removes a potential restriction on the company's ability to either make dividend payments and other distributions or to purchase its own shares in the future.

----------

ACG Acquisition Co Ltd - Special purpose acquisition company looking to benefit from favourable price conditions for new economy metals and other mining materials - In June, ACG said it will be renamed to ACG Electric Metals Ltd as it invests in two Brazilian mines to supply metals to electric vehicle makers. ACG Acquisition said it purchased the Atlantic nickel sulphide mine and the Mineracao Vale Verde copper mine in Brazil for USD1.0 billion from funds advised by Appian Capital Advisory LLP, as it looks to become a "new leader in green critical metals". On Tuesday, it says it has postpone its equity offer amid asset purchase talks. "ACG is discussing potential improvements to the transaction structure," the company says. It noted that it has paused the book building process for the placing for a "short period of time" and will reschedule the acquisition extraordinary general meeting to a later date in July. The scheduled date for the completion of the acquisition and settlement of the placing remains August 4.

----------

BioPharma Credit PLC - specialist life sciences debt investment trust - Notes filing by LumiraDx Ltd which discloses an amendment to the loan agreement entered into with BioPharma Credit, BPCR LP, and BioPharma Credit Investments V (Master) LP. On Monday, LumiraDx said it had amended its loan agreement, by extending the time it has to comply with certain minimum net sales and minimum liquidity covenants in the agreement until July 20.

----------

Litigation Capital Management Ltd - asset manager specialising in dispute financing solutions - Says it has reviewed its accounting policies and will now transition to fair value accounting. Says that this will put LCM in line with industry peers in both accounting policy and fair value framework. In doing so, it expects to announce its financial 2023 results under both the existing accounting policies as well as the newly adopted fair value accounting. "This will provide our investors with better transparency on the impact of the transition," it says. Adds that it has decided to pay a dividend of 2.25p to shareholders for financial 2023. CEO Patrick Moloney comments: "We are pleased with the performance of the business over the past 12 months, particularly as we begin to see the benefits of moving to a fund management business model. Our strong financial performance is the best in LCM's history and reflected in the board's decision to pay a dividend."

----------

Investment Co PLC - Newton Abbot, London-based investment trust - Tenders 4.0 million shares, constituting around 83% of the existing share capital. In addition, it receives total commitments of approximately GBP3.6 million pursuant to its placing, offer for subscription and intermediaries offer. The issue price will be calculated on or around 1800 BST Tuesday.

----------

Andrada Mining Ltd - Technology metals mining company with a portfolio of mining and exploration assets in Namibia - Raises GBP7.7 million through the issue of 77 unsecured, convertible loan notes of GBP100,000 each to new and existing investors. Also confirm that it has also completed the construction phase of the bulk sampling plant and tantalum circuit. CEO Anthony Viljoen says: "The proceeds are to be used for ongoing capital expansion programmes related to the lithium and tantalum development. In addition, the funds will be used for working capital purposes as Andrada progresses its exploration programme, and commences a lithium feasibility study, to further consolidate its competitive lithium advantage within the Erongo region of Namibia."

----------

Topps Tiles PLC - Leicestershire-based retailer - Notes shareholder disapproval at annual general meeting on January 18. At the time resolution 15 - short notice for meetings other than AGMs - did not pass, seven others passed with less than 80% of votes cast in favour. Says that since then the board has engaged with the relevant shareholder to understand and discuss their views with respect to these resolutions. "Whilst the board fully respects and acknowledges that a shareholder may choose to vote against specific resolutions, the board considers all the resolutions proposed to be in the best interests of all shareholders," Topps adds.

----------

CPPGroup PLC - Leeds, England-based technology-driven assistance company - Expects revenue from continuing operations in the first half of 2023 to be about 22% ahead of the prior year, and, on a constant currency basis, to be ahead of the prior year by 26%. Earnings before interest, tax, depreciation and amortisation from continuing operations is expected to be broadly in line with the prior year at about GBP2.9 million, unchanged from GBP2.9 million in the first half of 2022. CEO Simon Pyper says: "From a trading perspective the group's performance in the first half was encouraging. Additionally, growth, renewals, and new client wins in Blink provide strong evidence that our strategy and approach is appropriate, and more importantly, starting to deliver positive outcomes, though at a somewhat more measured pace than originally expected." Plans to publish its interim results for the first half of the year on September 19.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Oct 2016 11:01

Ixico pens deal to help develop a therapy for Parkinson's like diesease

(ShareCast News) - Shares in AIM-listed Ixico rose above 22% on Thursday, as the brain health company announced it had signed a $1.2m contract with a global pharmaceutical for imaging clinical trial services for a Parkinson's-like neurodegenerative disease. The project is for a second phase clinical

Read more
10 Oct 2016 12:26

Ixico to receive €1m from EU Alzheimer's project

(ShareCast News) - AIM-listed pharmaceutical Ixico is to receive €1m as a partner in an EU public-private consortium, which has the potential for long-term revenue through the development of diagnostic and disease management technologies for Alzheimer's. Ixico is to work on the Amyloid Imaging to Pr

Read more
2 Jun 2016 16:27

IXICO study joins Dementias Platform

(ShareCast News) - Brain health company IXICO announced on Thursday that its Cygnus study has joined the high-profile Dementias Platform UK (DPUK). The AIM-traded firm described Cygnus as a real-world digital data collection study from people with cognitive impairment and dementia. It said the four

Read more
18 Jan 2016 13:51

Ixico wins four new contracts worth over £3m

(ShareCast News) - Brain health company Ixico was recently awarded four new contracts with "leading" pharmaceutical groups and a specialist biotechnology firm totalling over £3m in value. The contracts involve global clinical trials of novel drugs for Alzheimer's disease spanning three major phases

Read more
19 Oct 2015 12:33

Ixico full-year income in line with expectations

(ShareCast News) - Brain health company Ixico reported revenues for the year of £3.1m and other income at £1m, in line with market expectations and giving a total combined income of £4.1m. This was down from £4.3m for the 16-month period to 30 September 2014. In a pre-close trading update ahead of

Read more
29 Jun 2015 11:11

Ixico secures two clinical trial contracts alongside partner VirtualScopics

Ixico has won two contracts to deploy its products in unnamed pharmaceutical companies' clinical trials, alongside its partner VirtualScopics. Both studies will employ Ixico's TrialTracker digital platform to collect and image data, one pertaining to metastatic solid tumours and the other to rare ne

Read more
17 Sep 2014 08:48

IXICO Appoints CFO For October 1 Start

Read more
21 Jul 2014 15:45

DIRECTOR DEALINGS: IXICO Divisional Vice-President Buys Shares

Read more
18 Jul 2014 07:25

UK MORNING BRIEFING: Shares Lower On Ukraine Crash, Gaza Offensive

Read more
19 Jun 2014 10:40

IXICO Joins Medical Research Council Collaboration For Dementia Drive

LONDON (Alliance News) - IXICO PLC said Thursday it will take part in a GBP16 million collaboration launched by publicly funded government agency the Medical Research Council to speed up research into dementia. The MRC has launched the UK Dementias Research Platform with the aim of seeking

Read more
19 Jun 2014 08:30

Ixico partners with the Medical Research Council to launch UK Dementias Research Platform

Biotechnology group Ixico has partnered with the Medical Research Council (MRC) to launch the UK Dementias Research Platform (UKDP), a £16m public-private partnership. The group, which set up the partnership to speed up research into dementias, will act as the MRC's imaging partner on the project a

Read more
6 Jun 2014 09:20

IXICO To Meet Full-Year Expectations As Interim Hit By Listing Costs

LONDON (Alliance News) - IXICO PLC expressed confidence Friday in meeting market expectations for the full year, as it swung into a loss in the half year to end-March, hit by costs relating to its AIM listing and a decline in revenues. The company was formed via the reverse takeover of Phyt

Read more
22 May 2014 12:07

IXICO Wins Contracts For Huntington's Disease Clinical Trials

LONDON (Alliance News) - Brain health company IXICO PLC Thursday said it has won contracts for two separate clinical trials in Huntington's disease with "top 15" pharmaceutical companies, building on a third clinical study already underway on the disease. In a statement, IXICO said the two

Read more
16 Apr 2014 09:54

IXICO Awarded Development Contract By NHS England Initiative

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they

Read more
16 Apr 2014 07:33

UK MORNING BRIEFING: RSA Loses UK & Western Europe Chief Executive

LONDON (Alliance News) - RSA Insurance Group said Wednesday the Chief Executive of the business which houses its troubled Irish operations has resigned in order to become Executive Chairman, underwriting and distribution, at business partner A J.Gallagher. The company said UK & Western Euro

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.